NF1 MUTATION

Clinical trials for NF1 MUTATION explained in plain language.

Never miss a new study

Get alerted when new NF1 MUTATION trials appear

Sign up with your email to follow new studies for NF1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Terminated 1

New cancer drug trial halted early: what we know

Disease control Terminated

This early-stage trial tested a new drug called DCC-3084, alone or with other cancer treatments, in 29 people with advanced solid tumors that have specific genetic changes (MAPK pathway). The study was stopped early, so results are limited. The goal was to find safe doses and see…

Matched conditions: NF1 MUTATION

Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control

Last updated May 13, 2026 16:04 UTC

NF1 MUTATION

Get alerted when new NF1 MUTATION trials appear

New cancer drug trial halted early: what we know